Therefore, we investigated that whether VRK2 variants affect tumor cell proliferation, and the results showed that when compared to 167V VRK2, 167I VRK2 reduced dysbindin and increased cyclin D levels, leading to greater tumor cell proliferation. Here, DTNBP1 is linked to neoplasm.